There appear to be a couple of other players in this market thou not as far along as us.
http://www.genomeweb.com/proteomics/healthlinx-launches-ovplex-uk-heating-race-get-ovarian-cancer-dx-market
They look like American outfits targeting their market first.
Not much available on the web that is not advertising.
So IMO with first mover advantage and a better reliability after these next tests we look good...
